Process for the preparation of cPLA2 inhibitors

Details for Australian Patent Application No. 2004261567 (hide)

Owner Wyeth

Inventors Raveendranath, Panolil; Wu, Yanzhong

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2004261567

PCT Pub. Number WO2005/012238

Priority 60/490,005 25.07.03 US

Filing date 19 July 2004

Wipo publication date 10 February 2005

International Classifications

C07C 303/40 (2006.01) Preparation of esters or amides of sulfuric acids

C07C 311/13 (2006.01) Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups

C07D 209/14 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 209/22 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

Event Publications

16 February 2006 PCT application entered the National Phase

  PCT publication WO2005/012238 Priority application(s): WO2005/012238

16 February 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004261569-Method and compositions for coating glass and ceramic substrates

2004261561-Process for controlling crystal structure of risedronate